Abstract
The purpose of this study is to describe telehealth experiences and quality of HIV care provided to an urban population of people with HIV (PWH) in Washington, DC. We used self-reported survey data from a cohort of PWH in the DC Cohort longitudinal study linked to medical records (October 26, 2020–December 31, 2021). Analyses followed a mixed-methods approach, including prevalence estimates and multivariable logistic regression of telehealth use by demographic and HIV characteristics. We measured primary motivation, modes of engagement, and telehealth satisfaction. Qualitative responses to open-ended questions were coded using collaborative coding. A framework developed by the National Quality Forum (NQF) was applied to the results. Among 978 participants, 69% reported using telehealth for HIV care during the pandemic. High school graduates were less likely to use telehealth compared to those with college education (aOR 0.69, 95% CI 0.48, 0.98). PWH with > 1 co-morbid condition were more likely to use telehealth compared to those without (aOR 1.42, 95% CI 1.02, 1.95). The majority reported satisfaction with telehealth (81%). Qualitative analysis of telehealth satisfaction found that most responses were related to access to care and technology, effectiveness, and patient experience. PWH using telehealth during the pandemic were satisfied with their experience though use differed demographically. Telehealth was used effectively to overcome barriers to care engagement, including transportation, costs, and time. As we transition away from the emergency pandemic responses, it will be important to determine how this technology can be used in the future in an equitable manner to further strengthen HIV care engagement.
Similar content being viewed by others
Abbreviations
- EMR:
-
Electronic medical record
- NQF:
-
National Quality Forum
- PWH:
-
Persons with HIV
References
Johns Hopkins University. The center for systems science and engineering. COVID-19 dashboard. 2021 [cited 2022 Nov 28]. Available from: https://www.coronavirus.jhu.edu/map.html.
Ohl M, et al. Mixed-methods evaluation of a telehealth collaborative care program for persons with HIV infection in a rural setting. J Gen Intern Med. 2013;28(9):1165–73.
Kane CK, Gillis K. The use of telemedicine by physicians: still the exception rather than the rule. Health Aff (Millwood). 2018;37(12):1923–30.
Appropriations, House Budget, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, in Public Law No: 116-123 (03/06/2020), H.R.t.t.C.-. Congress, editor. 2020.
US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. Updated national survey trends in telehealth utilization and modality (2021–2022). 2023 Feb 7. Available from: https://aspe.hhs.gov/reports/updated-hps-telehealth-analysis-2021-2022.
Young JD, et al. Infectious Diseases Society of America position statement on telehealth and telemedicine as applied to the practice of infectious diseases. Clin Infect Dis. 2019;68(9):1437–43.
Centers for Disease Control and Prevention. Telehealth and telemedicine. 2023 Feb 7. Available from: https://www.cdc.gov/phlp/publications/topic/telehealth.html.
Telehealth.HHS.GOV. 2023 Feb 7. Available from: https://telehealth.hhs.gov/.
Nitiema P. Telehealth before and during the COVID-19 pandemic: analysis of health care workers’ opinions. J Med Internet Res. 2022;24(2): e29519.
Miller MJ, et al. Patient experience after modifying visit delivery during the COVID-19 pandemic. Am J Manag Care. 2021;27(2):e54–63.
Fadul N, et al. A Midwestern academic HIV clinic operation during the COVID-19 pandemic: implementation strategy and preliminary outcomes. J Int Assoc Provid AIDS Care. 2021;20:23259582211041424.
Mayer KH, et al. Rapid migration to telemedicine in a Boston community health center is associated with maintenance of effective engagement in HIV care. Open Forum Infect Dis. 2020;7(Suppl 1):S337–8.
Harsono D, et al. Experiences with telemedicine for HIV care during the COVID-19 pandemic: a mixed-methods study. AIDS Behav. 2022;26(6):2099–111.
National Quality Forum. 2021. Rural telehealth and healthcare system readiness measurement framework. Washington, DC. Available at: https://www.qualityforum.org/Publications/2021/11/Rural_Telehealth_and_Healthcare_System_Readiness_Measurement_Framework_-_Final_Report.aspx.
Greenberg AE, et al. Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions. J Am Med Inform Assoc. 2016;23(3):635–43.
Harris PA, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
Harris PA, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Kaiser Permanente. KP Research Bank COVID-19 surveys. 2020. 2023 Feb 9. Available from: https://researchbank.kaiserpermanente.org/wp-content/uploads/2021/05/KPRB-COVID-19-Survey_-summary.pdf.
Wilbourn B, et al. Characterization of HIV risk behaviors and clusters using HIV-transmission cluster engine among a cohort of persons living with HIV in Washington, DC. AIDS Res Hum Retrovir. 2021;37(9):706–15.
Stanford. COVID19 interview items for vulnerable populations. 2020. 2023 Feb 9. Available from: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#stanford.
Behar-Zusman V, Chavez JV, Gattamorta K. Developing a measure of the impact of COVID-19 social distancing on household conflict and cohesion. Fam Process. 2020;59(3):1045–59 (9 Feb 2023).
ATN. COVID Questionnaire Draft. 2020. 2023 Feb 9. Available from: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#atn.
CDC. Human infection with 2019 novel coronavirus case report form interviewer information case classification and identification. 2023 Feb 9. Available from: https://www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
City University of New York Institute for Implementation Science in Population Health. Baseline Questionnaire for the Communities, Households and SARS/COV-2 Epidemiology (CHASE) COVID Study. March 31, 2020. Available from: https://cunyisph.org/wp-content/uploads/CHASE-COVID_baseline_V2.1.pdf.
Kalichman S. Kalichman Covid-19 Assessment. 2020. Available from: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#kalichman-covid-19-assessment.
Creswell JW, et al. National Institutes of Health. 2011. Best practices for mixed methods research in the health sciences. Bethesda. Available at: https://obssr.od.nih.gov/sites/obssr/files/Best_Practices_for_Mixed_Methods_Research.
ATLAS.ti Scientific Software Development GmbH [ATLAS.ti 22 Windows]. 2022.
Smaling A. Varieties of methodological intersubjectivity—the relations with qualitative and quantitative research, and with objectivity. Qual Quant. 1992;26:169–80.
Labisi T, et al. HIV care meets telehealth: a review of successes, disparities, and unresolved challenges. Curr HIV/AIDS Rep. 2022;19(5):446–53.
Ennis N, Armas L, Butame S, Joshi H. Factors impacting video telehealth appointment completion during COVID-19 pandemic among people living with HIV in a community-based health system. AIDS Behav. 2021;6(2):407–14.
Friedman EE, Devlin SA, Gilson SF, Ridgway JP. Age and racial disparities in telehealth use among people with HIV during the COVID-19 pandemic. AIDS Behav. 2022;26(8):2686–91.
Auchus IC, et al. Transitioning to telehealth during the COVID-19 pandemic: patient perspectives and attendance at an HIV clinic in San Francisco. AIDS Patient Care STDS. 2021;35(7):249–54.
Grove M, Brown LB, Knudsen HK, Martin EG, Garner BR. Employing telehealth within HIV care: advantages, challenges, and recommendations. AIDS. 2021;35(8):1328–30.
Smith E, Badowski ME. Telemedicine for HIV care: current status and future prospects. HIV AIDS (Auckl). 2021;13:651–6.
Budak JZ, et al. The impact of COVID-19 on HIV care provided via telemedicine-past, present, and future. Curr HIV/AIDS Rep. 2021;18(2):98–104.
Spears CE, et al. Intersecting epidemics: the impact of coronavirus disease 2019 on the HIV prevention and care continua in the United States. AIDS. 2022;36(13):1749–59.
Dandachi D, et al. Integration of telehealth services in the healthcare system: with emphasis on the experience of patients living with HIV. J Investig Med. 2019;67(5):815–20.
Bouabida K, et al. Healthcare professional perspectives on the use of remote patient-monitoring platforms during the COVID-19 pandemic: a cross-sectional study. J Pers Med. 2022;12(4):529.
Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, Singh T, Aberg JA. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021;73(11):e3572–605.
Patel MC, Young JD. Delivering HIV subspecialty care in prisons utilizing telemedicine. Dis Mon. 2014;60(5):196–200.
Castaño PM, Stockwell MS, Malbon KM. Using digital technologies to improve treatment adherence. Clin Obstet Gynecol. 2013;56(3):434–45.
Koay WLA, et al. Brief report: supporting access to HIV care for children and youth during the COVID-19 pandemic with telemedicine and rideshare. J Acquir Immune Defic Syndr. 2021;88(4):384–8.
Campbell BR, et al. PositiveLinks and the COVID-19 response: importance of low-barrier messaging for PLWH in non-urban Virginia in a crisis. AIDS Behav. 2021;25(11):3519–27.
Collins LF, et al. The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the United States: applying lessons from high-burden settings. AIDS. 2021;35(2):337–41.
Acknowledgements
Data in this manuscript were collected by the DC Cohort Study Group with investigators and research staff located at: Children’s National Hospital Pediatric clinic (Natella Rakhmanina); the Senior Deputy Director of the DC Department of Health HAHSTA (Clover Barnes); Family and Medical Counseling Service (Angela Wood); Georgetown University (Princy Kumar); The George Washington University Biostatistics Center (Tsedenia Bezabeh, Vinay Bhandaru, Asare Buahin, Nisha Grover, Lisa Mele, Susan Reamer, Alla Sapozhnikova, Greg Strylewicz, and Marinella Temprosa); The George Washington University Department of Epidemiology (Shannon Barth, Morgan Byrne, Amanda Castel, Alan Greenberg, Shannon Hammerlund, Olivia Kirby, Paige Kulie, Anne Monroe, Lauren O’Connor, James Peterson, Bianca Stewart, and Mark Storey); The George Washington University Medical Faculty Associates (Jose Lucar); Howard University Adult Infectious Disease Clinic (Jhansi L. Gajjala) and Pediatric Clinic (Sohail Rana); Kaiser Permanente Mid-Atlantic States (Michael Horberg); La Clinica Del Pueblo (Ricardo Fernandez); MetroHealth (Duane Taylor); Washington Health Institute, formerly Providence Hospital (Jose Bordon); Unity Health Care (Gebeyehu Teferi); Veterans Affairs Medical Center (Debra Benator, Rachel Denyer); Washington Hospital Center (Adam Klein); and Whitman-Walker Institute (Stephen Abbott). The DC Cohort and COVID-19 supplement were funded by the National Institute of Allergy and Infectious Diseases, 1R24AI152598-01.
Funding
The DC Cohort and COVID-19 supplement were funded by the National Institute of Allergy and Infectious Diseases, 1R24AI152598-01. This research is funded by NIH Grant R24AI152598-01.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing Interests
Dr Barth: none; Dr Saulters: Alliance for Academic Internal Medicine, American College of Physicians 2021–2022, Paid to institution; Magnolia Regional Medical Center, Corinth MS 2020 and 2021, payment made to individual; Support for travel to Alliance for Academic Internal Medicine 2022, payment made to individual; Dr. Balba: Gilead, GlaxoSmithKline personal stocks; Dr. Kumar: Consulting fees from ViiV/GSK, Merck, Thera Technology, Johnson and Johnson, paid to individual; personal stocks in Pfizer, Gilead, Merck, Moderna, Johnson and Johnson; Dr. Greenberg: Invited speaker, Davidson College, paid to individual; DSMB/AB UW CFAR EAB (all unrelated), JHU CFAR EAB, ERC CFAR EAB, paid to individual; Dr. Castel: Research award from Gilead Sciences, Funding from National Institutes of Health, paid to individual; NIH NIDA Clinical Trials Network; personal stocks in Pfizer, Viatris, Inc.; Receipt of medications through Gilead Sciences grant as mentioned above, paid to institution.
Ethical Approval
The survey was approved by the George Washington University Institutional Review Board (IRB) and specific sites’ IRBs (Washington DC Department of Veterans Affairs, Washington Hospital Center, Children’s National Medical Center).
Informed Consent
Electronic informed consent was obtained from all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Barth, S.K., Saulters, K.J., Balba, G.P. et al. Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the COVID Pandemic Among Persons with HIV in Washington, DC. AIDS Behav 28, 912–923 (2024). https://doi.org/10.1007/s10461-023-04198-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-023-04198-7